A human homologue of SNCA was discovered in 1993 as the contributor to amyloid plaques deposition in Alzheimer's disease (AD) [3]; the first familial case of parkinsonism was described in 1997, showing a dominant inheritance pattern for an SNCA mutation (A53T) [4]. This evidence concerns the gene SNCA and amyloidosis.